Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Current Medicinal Chemistry|March 30, 2012
Recent advances in the development of 14-alkoxy substituted morphinans as potent and safer opioid analgesicsM Spetea, H SchmidhammerAnesthesia and Analgesia|May 29, 2000
14-methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dogE Freye, H Schmidhammer, L LataschDer Anaesthesist|September 1, 1992
[Pharmacodynamic effects of S-(+)-ketamine on EEG, evoked potentials and respiration. A study in the awake dog]E Freye, L Latasch, H SchmidhammerLife Sciences|May 11, 2002
Antinociceptive activity of a novel buprenorphine analogueR Lattanzi, L Negri, H Schmidhammer, et al.Life Sciences|May 16, 2000
Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetoponG Zernig, A Saria, R Krassnig, et al.Der Anaesthesist|November 1, 1994
[Interaction of S-(+)-ketamine with opiate receptors. Effects on EEG, evoked potentials and respiration in awake dogs]E Freye, L Latasch, H Schmidhammer, et al.Archiv Der Pharmazie|April 1, 1991
Synthesis and biological evaluation of 14-alkoxymorphinans, V: 6-Deoxyocyprodime, an opioid antagonist with decreased mu receptor selectivity in comparison to cyprodimeH Schmidhammer, H K Jennewein, C F SmithThe Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|April 1, 1989
Non-deleterious inhibition of endogenous peroxidase activity (EPA) by cyclopropanone hydrate: a definitive approachK W Schmid, A Hittmair, H Schmidhammer, et al.European Journal of Pharmacology|May 19, 1993
Highly potent novel opioid receptor agonist in the 14-alkoxymetopon seriesZ Fürst, B Búzás, T Friedmann, et al.Journal of Medicinal Chemistry|February 1, 1989
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonistH Schmidhammer, W P Burkard, L Eggstein-Aeppli, et al.Pageof 3